📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Polydex Pharmaceuticals

1.1 - Company Overview

Polydex Pharmaceuticals Logo

Polydex Pharmaceuticals

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, manufacturing and selling dextran and derivative products to large pharmaceutical companies globally. Under a definitive supply agreement with Sparhawk in the United States, provides ferric hydroxide and hydrogenated dextran through its U.S. subsidiary, Chemdex.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Polydex Pharmaceuticals

Syrrx Logo

Syrrx

HQ: United States Website
  • Description: Provider of drug discovery services leveraging high-throughput structural biology, focusing on drug targets validated in human clinical trials and directing efforts toward therapeutics for metabolic diseases, cancer, and inflammation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Syrrx company profile →
Albuquerque Neuroscience Logo

Albuquerque Neuroscience

HQ: United States Website
  • Description: Provider of high-quality research focused on human diseases of the central nervous system (CNS), particularly psychiatric disorders; specialized in CNS diseases and general medical conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Albuquerque Neuroscience company profile →
Elligo Health Research Logo

Elligo Health Research

HQ: United States Website
  • Description: Provider of clinical research solutions that bring research to physician practices to accelerate the development of medical devices and therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Elligo Health Research company profile →
Batavia Biosciences Logo

Batavia Biosciences

HQ: The Netherlands Website
  • Description: Provider of services accelerating the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost, including candidate selection, production of research materials, upstream and downstream process development, assay development, and product characterization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Batavia Biosciences company profile →
Aptus Clinical Logo

Aptus Clinical

HQ: United Kingdom Website
  • Description: Provider of specialist clinical contract research services, offering Catalyst Oncology, a clinical research organization focusing on oncology supporting biotech companies in developing cancer therapies, and Catalyst Flex, multi-therapeutic functional service provider solutions including clinical operations, data management, biostatistics, programming, safety, and medical writing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aptus Clinical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Polydex Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Polydex Pharmaceuticals

2.2 - Growth funds investing in similar companies to Polydex Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Polydex Pharmaceuticals

4.2 - Public trading comparable groups for Polydex Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Polydex Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Polydex Pharmaceuticals

What does Polydex Pharmaceuticals do?

Polydex Pharmaceuticals is a provider of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, manufacturing and selling dextran and derivative products to large pharmaceutical companies globally. Under a definitive supply agreement with Sparhawk in the United States, provides ferric hydroxide and hydrogenated dextran through its U.S. subsidiary, Chemdex.

Who are Polydex Pharmaceuticals's competitors?

Polydex Pharmaceuticals's competitors and similar companies include Syrrx, Albuquerque Neuroscience, Elligo Health Research, Batavia Biosciences, and Aptus Clinical.

Where is Polydex Pharmaceuticals headquartered?

Polydex Pharmaceuticals is headquartered in Canada.

How many employees does Polydex Pharmaceuticals have?

Polydex Pharmaceuticals has 1,000 employees 🔒.

When was Polydex Pharmaceuticals founded?

Polydex Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Polydex Pharmaceuticals in?

Polydex Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Polydex Pharmaceuticals

Who are the top strategic acquirers in Polydex Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Polydex Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Polydex Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Polydex Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Polydex Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Polydex Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Polydex Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Polydex Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Polydex Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Polydex Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Polydex Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Polydex Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Polydex Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Polydex Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Polydex Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Polydex Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Polydex Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Polydex Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Polydex Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Polydex Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Polydex Pharmaceuticals